Melita Perić Balja

The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status

Z. Gatalica, S. Vranić, F. Skenderi, 2023, Biomolecules & biomedicine.

Non-phosphorylated Tyr-1248 form of human epidermal growth factor receptor 2 (HER2) predicts resistance to trastuzumab therapy and poor disease-free survival of HER2-positive breast cancer patients

F. Knežević, I. Márton, S. Ramic, 2022, Croatian medical journal.